The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time

Oncology Reports

Volumn 16, Issue 3, 2006, Pages 555-562

  Nafe, Reinhold ^a   Franz, K E A ^a   Schlote, Wolfgang ^a   Schneider, Berthold ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Glioblastomas; Morphometry; Necrosis; Prognosis; Tumor cell nuclei

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER STAGING; CELL NUCLEUS; CELL PROLIFERATION; COMPARATIVE STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; BRAIN NEOPLASMS; CELL NUCLEUS; CELL PROLIFERATION; FEMALE; GLIOBLASTOMA; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33749189585     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.3.555     Document Type: Article

References (24)

1. Mineo JF, Quintin-Roue I, Lucas B, Buburusan V and Besson G: Glioblastomas: clinical study and search for prognostic factors. Neurochirurgie 48: 500-509, 2002. (Pubitemid 36168973)
2. Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W and Holowaty E: A population based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51: 100-107, 2001. (Pubitemid 32758868)
3. Schmidt MC, Antweiler S, Urban N, et al: Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61: 321-328, 2002. (Pubitemid 34266783)
4. Zagzag D, Blanco C, Friedlander DR, Miller DC and Newcomb EW: Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index and patient survival. Hum Pathol 34: 48-53, 2003. (Pubitemid 36160021)
5. Burger PC and Green SB: Patient age, histologic features and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617-1625, 1987. (Pubitemid 17060106)
6. Burton EC, Lamborn KR, Forsyth P, et al: Aberrant p53, mdm2 and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res 8: 180-187, 2002. (Pubitemid 34101475)
7. Nafe R, Franz K, Schlote W and Schneider B: Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas. Clin Cancer Res 11: 2141-2148, 2005. (Pubitemid 40490170)
8. Dong S, Nutt CL, Betensky RA, et al: Histology-based expression profiling yields novel prognostic markers in human glioblastoma. J Neuropathol Exp Neurol 64: 948-955, 2005. (Pubitemid 41668924)
9. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H and Cavenee WK: Glioblastoma. In: Pathology and Genetics of Tumours of the Nervous System. Kleihues P and Cavenee WK (eds). International Agency for Research on Cancer, IARC-Press, Lyon, pp29-39, 2000.
10. Nafe R, Glienke W, Schlote W and Schneider B: EGFR gene-amplification in glioblastomas - is there a relationship with morphology of tumor cell nuclei and proliferative activity? Analyt Quant Cytol Histol 23: 135-143, 2001. (Pubitemid 32378086)
11. Nafe R, Herminghaus S, Raab P, et al: Correlation between preoperative magnetic resonance spectroscopic data on high grade gliomas and morphology of Ki-67-positive tumor cell nuclei. Analyt Quant Cytol Histol 25: 131-138, 2003. (Pubitemid 36702639)
12. Nafe R and Schneider B: Data analysis for comparative histometry in pathology - I. classification procedures and other statistical methods. E J Pathol 6: 002-03.txt, 2000.
13. Scott JN, Rewcastle NB, Brasher PMA, et al: Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46: 183-188, 1999. (Pubitemid 29382874)
14. Cuny E, Loiseau H, Penchet G, et al: Association of elevated glial expression of interleukin-1β with improved survival in patients with glioblastomas multiforme. J Neurosurg 96: 294-301, 2002. (Pubitemid 34230244)
15. Rich JN, Hans C, Jones B, et al: Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65: 4051-4058, 2005. (Pubitemid 40775641)
16. Raza SM, Lang FF, Aggarwal BB, et al: Necrosis and glioblastoma: a friend or a Foe? A review and hypothesis. Neurosurgery 51: 2-13, 2002. (Pubitemid 36331094)
17. Pierallini A, Bonamini M, Pantano P, et al: Radiological assessment of necrosis in glioblastoma: variability and prognostic value. Neuroradiology 40: 150-153, 1998. (Pubitemid 28438823)
18. Brat DJ and van Meir EG: Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis and accelerated growth in glioblastoma. Lab Invest 84: 397-405, 2004. (Pubitemid 41656467)
19. Brat DJ, Castellano-Sanchez AA, Hunter SB, et al: Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64: 920-927, 2004. (Pubitemid 38176893)
20. Graeber TG, Osmanian C, Jacks T, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996. (Pubitemid 26008141)
21. Fadok VA, Bratton DL, Rose DM, et al: A receptor for phosphatidylserine specific clearance of apoptotic cells. Nature 405: 85-90, 2000. (Pubitemid 30321820)
22. Cervoni L, Celli P and Salvati M: Long-term survival in a patient with supratentorial glioblastoma: clinical considerations. Ital J Neurol Sci 19: 221-224, 1998. (Pubitemid 128730538)
23. Hayashi Y, Yamashita J and Watanabe T: Molecular genetic analysis of deep-seated glioblastomas. Cancer Genet Cytogenet 153: 64-68, 2004. (Pubitemid 39592132)
24. Nafe R, Glienke W, Burgemeister R, et al: Regional heterogeneity of EGFR gene amplification and nuclear morphology in glioblastomas. Analyt Quant Cytol Histol 26: 65-76, 2004.